Aims and objectives

The ESCMID Study Group for Host and Microbiota Interactions (ESGHAMI) is leading the way in bridging diagnostics, clinical research, and scientific studies across the relatively new field of microbiota research in Europe. Together, we seek to understand the clinical significance of host-microbiota associated diseases and health, and explore relevant therapeutic interventions. Our research covers:

  • Intestinal, urogenital, respiratory, and skin microbiota of both humans and animals
  • Interactions of microbiota with the host immune response

Activities and resources

ESGHAMI Newsletter, Spring 2023, April 2023


ESGHAMI Newsletter, Spring 2023, May 2023


ESGHAMI Newsletter, Summer 2023, June 2023


ESGHAMI Newsletter, Summer 2023, September 2023


ESGHAMI Newsletter, Winter 2023, December 2023


Which trial do we need? A sequential multiple assignment randomized trial to determine the optimal Clostridioides difficile treatment sequence.

van Prehn J, van Werkhoven CH, Skinner AM, Guery B, Dubberke ER, Kuijper EJ. Clinical Microbiology and Infection 2024;30(2):165–169.

Go to publication

Faecal microbiota transplantation for first and second episodes of Clostridioides difficile infection.

van Prehn J, Fitzpatrick F, Kuijper EJ. Lancet Gastroenterol Hepatol. 2022;7(12):1083–1091.

Go to publication

Bacteriophage therapy in humans.

Nir-Paz R, Kuijper EJ. Clin Microbiol Infect. 2023;29(6):679–681.

Go to publication

Update on Microbiota-derived therapies for recurrent Clostridioides difficile infections, 2023.

Benech N, Barbut N, Fitzpatrick F, Krutova M, Davies K, Druart C, Cordaillat-Simmons M, hHeritage J, Guery B, Kuijper E. Clinical Microbiology and Infection. 2023:S1198-743X(23)00597-9.

Go to publication

Faecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma

Update on Live biotherapeutic products and FMT-like treatments for recurrent Clostridioides difficile infections

21 June 2023

Go to webinar

Microbiome from benchtop to bedside technical workshop

Executive Committee

  Ed J. Kuijper

Ed J. Kuijper

LUMC. Medical Microbiology.
Leiden, Netherlands
  Christophe Van Dijck

Christophe Van Dijck

Institute of Tropical Medicine Antwerp. Clinical Sciences.
Antwerp, Belgium
  Lesley Hoyles

Lesley Hoyles

Nottingham Trent University. Biosciences.
Nottingham, United Kingdom


If you have questions or comments for our study group, we warmly invite you to contact us!

Contact form